Roche Acquires InflazomeAcquisitions, Business, Cryopyrin-Associated Periodic Syndrome (CAPS), Deals, FDA, Financing, Inflammasome Inhibitors, Inflammatory Diseases, Investors, NLRP3 Gene, Orphan Drug Designation, Small MoleculesSwiss pharma giant Roche acquired Ireland’s Inflazome and the company’s NLRP3 inflammasome inhibitors aimed at multiple inflammatory diseases. Read more September 21, 2020/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/09/Roche-Dives-into-NLRP3-Inflammasome-Inhibition-with-Acquisition-of-Inflazome-BioSpace-9-21-20.jpeg 350 625 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2020-09-21 11:28:522020-09-21 12:45:51Roche Acquires Inflazome